Show simple item record

HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era

dc.contributor.authorEvans, Cen_US
dc.contributor.authorHumphrey, JHen_US
dc.contributor.authorNtozini, Ren_US
dc.contributor.authorPrendergast, AJen_US
dc.date.accessioned2019-02-27T13:08:13Z
dc.date.available2016-05-02en_US
dc.date.issued2016-06-06en_US
dc.identifier.issn1664-3224en_US
dc.identifier.otherARTN 190
dc.identifier.otherARTN 190en_US
dc.identifier.otherARTN 190en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/55586
dc.description.sponsorshipThe ZVITAMBO trial was supported by the Canadian International Development Agency (CIDA) (R/C Project 690/M3688), United States Agency for International Development (USAID) (cooperative agreement number HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition – USAID) and a grant from the Bill and Melinda Gates Foundation, Seattle, WA, USA. Additional funding was received from the SARA Project, which is operated by the Academy for Educational Development, Washington DC and is funded by USAID’s Bureau for Africa, Office of Sustainable Development under the terms of Contract AOT-C-00-99-00237-00, the Rockefeller Foundation (New York, NY), and BASF (Ludwigshafen, Germany). CE is funded by the National Institute for Health Research. AJP is funded by the Wellcome Trust (108065/Z/15/Z).en_US
dc.language.isoenen_US
dc.relation.ispartofFRONTIERS IN IMMUNOLOGYen_US
dc.rightsCreative Commons Attribution License
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectHIV exposureen_US
dc.subjectinfanten_US
dc.subjectZimbabween_US
dc.subjectAfricaen_US
dc.subjectinflammationen_US
dc.subjectimmune activationen_US
dc.subjectbreast-feedingen_US
dc.titleHIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Eraen_US
dc.typeArticle
dc.rights.holder2016 Evans, Humphrey, Ntozini and Prendergast.
dc.identifier.doi10.3389/fimmu.2016.00190en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377060800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume7en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderThe impact of cotrimoxazole on healthly birth and growth in rural Zimbabwe::Wellcome Trusten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License